Search clinical trials for: induction therapy

Total 53958 results

Clinica Universidad de Navarra, Universidad de...

Completed

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Adenocarcinoma | Gastrointestinal Neoplasms | Gastric Cancer | Surgery | Effects of Chemotherapy

Spain
Asan Medical Center

Unknown

Thymoglobulin Induction Therapy in Kidney Transplantation (6mg/kg vs 4mg/kg)

Kidney Failure
New York Presbyterian Brooklyn Methodist Hospital

Withdrawn

Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.) (HELP)

Hepatic Encephalopathy | Cirrhosis | Altered Mental Status | HE | AMS

United States
Nantes University Hospital

Unknown

A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids

Kidney Transplantation | Pancreas Transplantation

France
Emory University
Sanofi; Georgia Center for Oncology Research & Education

Completed

Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer

Breast Cancer

United States
Ankara University

Completed

Does Repetitive Electroconvulsive Therapies Affect Propofol Induction Dose ?

Electroconvulsive Therapy | Physiatrics
Meir Medical Center
Clalit Health Services; Reidman college

Unknown

Does Acupuncture Therapy Reduce the Need for Labor Induction After Postdate (Week 41)

Post-term Pregnancy (40 to 42 Weeks Gestation)

Israel
Genzyme, a Sanofi Company

Completed

An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

Cadaveric Donor Renal Transplantation | Acute Renal Allograft Rejection | Induction Therapy

United States, France, Spain, United Kingdom, Germany
Genzyme, a Sanofi Company

Completed

Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection

Liver Dysfunction | Transplantation, Liver | Rejection, Transplant

United States, Canada
Genzyme, a Sanofi Company

Completed

A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection

Graft Rejection | Renal Transplantation

United States
UCB Pharma

Completed

Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (NCT00291668)

Crohn's Disease

Japan
Baylor College of Medicine

Completed

Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation

Kidney Cancer

United States
Hoffmann-La Roche

Completed

INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.

HIV Infections

France
Tel-Aviv Sourasky Medical Center

Unknown

The Effect of Pullsed Magnetic Field Induction on Improving the Forearm Tissue Muscle Performance

Medical Oncology

Israel
Assiut University

Unknown

Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas

Cancer of Pancreas

Egypt
Janssen-Cilag G.m.b.H

Completed

A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy

Multiple Myeloma

Germany
Guangdong Provincial People's Hospital

Unknown

Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia

Acute Myeloid Leukemia
Yale University
Celgene Corporation

Terminated

Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
Cristina Gasparetto
Celgene Corporation

Completed

Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy

Multiple Myeloma

United States
Duke University

Completed

Intensive Induction Therapy Followed by High Dose Chemo and BM Transplant for Mantle Cell Lymphoma

Mantle Cell Lymphoma
Feng Jing

Unknown

Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study

Nasopharyngeal Carcinoma

China
Medical Research Council
GlaxoSmithKline; Department for International Development, United Kingdom; ViiV...

Completed

Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa (ARROW)

Human Immunodeficiency Virus

Uganda, Zimbabwe
University Hospital, Udine, Italy

Completed

Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML) (MYFLAI07)

Acute Myeloid Leukemia

Italy
Rambam Health Care Campus

Unknown

Rapid Profiling of Bone Marrow, at Presentation and After 5 Days of Induction Therapy

AML

Israel
University of Michigan Rogel Cancer Center

Completed

Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC

Extensive-Stage Small Cell Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb

Completed

Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Leukemia | Acute Lymphoblastic Leukemia

United States
Icahn School of Medicine at Mount Sinai

Completed

Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy

Head and Neck Cancer | Oropharyngeal Cancer | Human Papillomavirus | Squamous Cell Cancer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy

Leukemia

United States, Canada, Australia, Puerto Rico, Switzerland
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma

Neuroblastoma

United States, Australia
Armando Santoro, MD

Unknown

Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients

Hodgkin's Lymphoma

Italy
University of California, San Francisco
National Cancer Institute (NCI)

Unknown

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Lymphoma | Kidney Cancer | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

United States
Northside Hospital, Inc.
Blood and Marrow Transplant Group of Georgia

Terminated

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Diseases

United States
Milton S. Hershey Medical Center

Unknown

Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors

Unspecified Childhood Solid Tumor, Protocol Specific

United States
Medical Research Council

Completed

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease

Lymphoma

United Kingdom
Austrian Forum Against Cancer

Completed

Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy

Multiple Myeloma

Austria
Austrian Forum Against Cancer

Completed

Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy

Multiple Myeloma

Austria
Nantes University Hospital

Terminated

Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response

Hepatocellular Carcinoma

France
Millennium Pharmaceuticals, Inc.

Withdrawn

A Phase 2 Study of Tandutinib in Patients With Newly Diagnosed Acute Myelogenous Leukemia Who Are Considered Ineligible For or Who Decline Treatment With Standard Induction Therapy

Acute Myelogenous Leukemia
Taipei Veterans General Hospital, Taiwan

Completed

Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic Control

Type 2 Diabetes

Taiwan
Clavis Pharma
Syneos Health; Theradex

Completed

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

Acute Myeloid Leukemia

United States, Norway, Germany, France
St. Anna Kinderkrebsforschung

Unknown

Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation

Neuroblastoma

Austria
Children's Cancer and Leukaemia Group

Unknown

Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors

Ovarian Cancer | Extragonadal Germ Cell Tumor | Childhood Germ Cell Tumor

United Kingdom, Ireland
Military Institute of Medicine, Poland

Completed

The Influence of Induction Anesthetic Agents on Serum Cortisol Concentration in Morbidly Obese Patients.

Obesity

Poland
Eli Lilly and Company

Completed

Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy

Advanced Solid Tumors

United States
Sun Yat-sen University

Unknown

Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC (NPC)

Nasopharyngeal Carcinoma

China
Washington University School of Medicine

Completed

Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML (CLAG ATRA AML)

Leukemia, Myeloid, Acute

United States
University Hospital, Antwerp
Eli Lilly and Company; Universiteit Antwerpen

Completed

Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC (CHER@NOS)

Non-Small-Cell-Lung Cancer

Belgium
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Lung Cancer

United States
Guangdong Provincial People's Hospital

Completed

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

China
University of California, Los Angeles
Genzyme, a Sanofi Company

Withdrawn

Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant Recipients

Heart Transplantation | Ischemia Reperfusion Injury

United States

3

Subscribe